Engineered Colon Cancer Tissue to Examine the Role of the Obese Microenvironment in Tumor Aggressiveness
改造结肠癌组织以检查肥胖微环境在肿瘤侵袭性中的作用
基本信息
- 批准号:10650412
- 负责人:
- 金额:$ 52.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdipocytesAdipose tissueAffectBedsBenchmarkingBioinformaticsBiological AssayBiomimeticsCancer ModelCell LineCellsClinical DataClinical OncologyCoculture TechniquesColon AdenocarcinomaColon CarcinomaColorectal CancerComplexConditioned Culture MediaConsensusCuesDiseaseDisease ProgressionEngineeringEpidemiologyExtracellular MatrixGene ExpressionGenomicsGrowthHeterogeneityHumanImplantIn VitroInfiltrationInflammationInflammatoryInsulin ResistanceInvestigator-Initiated ResearchLinkMaintenanceMalignant NeoplasmsMechanicsMediatingMetabolicMetabolic DiseasesModelingMorbidity - disease rateMusObesityPathologicPathway interactionsPatientsPhenotypePopulationProliferatingPropertyProteomicsResearchRoleSignal PathwaySignal TransductionStromal CellsTechnologyTestingThe Cancer Genome AtlasThinnessTissue EngineeringTissuesTransforming Growth Factor betaTransplantationTumor BankValidationanticancer researchbioinformatics toolcancer cellcancer subtypesclinical practicecohortcolon cancer patientscolorectal cancer treatmentflexibilityimprovedin vitro Modelin vivoin vivo Modelmodel developmentmolecular subtypesmortalitypatient derived xenograft modelportabilityprimary outcomeresponseskillssystemic inflammatory responsetissue culturetooltranscriptome sequencingtranscriptomicstumortumor growthtumor microenvironmenttumor progressiontumor xenograft
项目摘要
Abstract
Modulation of the tumor microenvironment is known to promote the growth and survival of colorectal cancer
(CRC) cells. Strong epidemiological evidence links certain types of human cancer, including CRC, with obesity,
and the obese pathophysiological state has been shown experimentally to stimulate CRC tumor growth. However,
the mechanisms involved are not fully known: in particular, the impact of the obese tumor microenvironment on
CRC tumor cellular composition, stiffness, and ECM composition is not known. Further, pathophysiologically
relevant, patient-specific models for investigating obesity-linked inflammation mediated changes in the obese,
tumor microenvironment do not exist for CRC. Thus, the objective of the proposed project is to examine modulation
of the tumor microenvironment and obesity-related CRC disease progression using tissue-engineered patient
derived xenograft (PDX) CRC models validated through comparison to patient tumors and PDX tumors. Our
collaborative team will achieve this objective by leveraging their unique combined interdisciplinary expertise
in CRC, tissue engineering, obesity and metabolic disease, transcriptomics, proteomics, and bioinformatics.
We will use our improved models of CRC that replicate the cues found in the obese, insulin resistant/pro-
inflammatory tumor microenvironment to test the hypothesis that obesity alters stromal signaling in the
consensus molecular subtype 4 (CMS4) tumor microenvironment. To test our hypothesis, we have developed
a tissue-engineered platform that enables long-term in vitro culture of the patient-derived CRC cells and
recapitulation of the native tumor microenvironment, particularly the stromal component. The following
Specific Aims will be pursued: Aim 1. Determine the extent to which 3D in vitro engineered CMS4-derived CRC
tissues recapitulate patient and PDX tumors; Aim 2. Determine and compare the obesity mediated changes in
the stromal component and metastatic properties of CMS4-derived 3D engineered tissues and PDX tumors; and
Aim 3. Examine 3D engineered tissues, PDX tumors, and patient tumors from obese CRC patients for engineered
tissue refinement and obesity model validation.
This investigator-initiated research effort is in response to FOA PAR-19-113, Cancer Tissue Engineering
Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research. Overall, these efforts,
which employ state-of-the-art technologies to characterize and compare our paired models and human patient
tumors in an in-depth and rigorous manner, will develop a portable tissue-engineering platform with robust
cross-validation so that this tool can be used to uncover CRC subtype specific mechanisms of obesity-driven
tumor progression, as well as other parameters affecting CRC morbidity and mortality.
抽象的
已知调节肿瘤微环境可促进结直肠癌的生长和存活
(CRC)细胞。强有力的流行病学证据表明某些类型的人类癌症(包括结直肠癌)与肥胖有关,
实验表明,肥胖的病理生理状态会刺激结直肠癌肿瘤的生长。然而,
所涉及的机制尚不完全清楚:特别是肥胖肿瘤微环境对
CRC 肿瘤细胞组成、硬度和 ECM 组成尚不清楚。此外,从病理生理学上
相关的、针对患者的特定模型,用于研究肥胖相关炎症介导的肥胖变化,
CRC 不存在肿瘤微环境。因此,拟议项目的目标是检查调制
使用组织工程患者研究肿瘤微环境和肥胖相关的结直肠癌疾病进展
通过与患者肿瘤和 PDX 肿瘤进行比较来验证衍生异种移植 (PDX) CRC 模型。我们的
协作团队将利用其独特的综合跨学科专业知识来实现这一目标
结直肠癌、组织工程、肥胖和代谢疾病、转录组学、蛋白质组学和生物信息学。
我们将使用我们改进的 CRC 模型来复制在肥胖、胰岛素抵抗/亲胰岛素人群中发现的线索。
炎症肿瘤微环境来检验肥胖改变基质信号传导的假设
共有分子亚型 4 (CMS4) 肿瘤微环境。为了检验我们的假设,我们开发了
一个组织工程平台,可以对源自患者的 CRC 细胞进行长期体外培养,并且
再现天然肿瘤微环境,特别是基质成分。下列
将追求的具体目标: 目标 1. 确定 3D 体外工程化 CMS4 衍生的 CRC 的程度
组织再现患者和 PDX 肿瘤;目标 2. 确定并比较肥胖介导的变化
CMS4 衍生的 3D 工程组织和 PDX 肿瘤的基质成分和转移特性;和
目标 3. 检查来自肥胖 CRC 患者的 3D 工程组织、PDX 肿瘤和患者肿瘤,以进行工程化
组织细化和肥胖模型验证。
这项由研究者发起的研究工作是为了响应 FOA PAR-19-113(癌症组织工程)
协作:为癌症研究提供仿生组织工程技术。总的来说,这些努力,
采用最先进的技术来表征和比较我们的配对模型和人类患者
深入、严谨地研究肿瘤,将开发一个具有强大功能的便携式组织工程平台
交叉验证,以便该工具可用于揭示肥胖驱动的 CRC 亚型特异性机制
肿瘤进展以及影响 CRC 发病率和死亡率的其他参数。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael W Greene其他文献
Michael W Greene的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael W Greene', 18)}}的其他基金
Engineered Colon Cancer Tissue to Examine the Role of the Obese Microenvironment in Tumor Aggressiveness
改造结肠癌组织以检查肥胖微环境在肿瘤侵袭性中的作用
- 批准号:
10522863 - 财政年份:2022
- 资助金额:
$ 52.19万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Recruitment of brown adipocytes in visceral white adipose tissue by fibroblast growth factor 8b
成纤维细胞生长因子 8b 将棕色脂肪细胞募集到内脏白色脂肪组织中
- 批准号:
321208980 - 财政年份:2016
- 资助金额:
$ 52.19万 - 项目类别:
Research Grants
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8827438 - 财政年份:2014
- 资助金额:
$ 52.19万 - 项目类别:
Induction of brown-like adipocytes in white adipose tissue by food-derived factors
食物源性因子在白色脂肪组织中诱导棕色样脂肪细胞
- 批准号:
26450168 - 财政年份:2014
- 资助金额:
$ 52.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
WAT-on-a-chip - Development of a micofluidic, microphysiologic in vitro adipose tissue model for high-throughput drug screening based on hiPSC-derived adipocytes.
WAT-on-a-chip - 开发微流体、微生理体外脂肪组织模型,用于基于 hiPSC 衍生脂肪细胞的高通量药物筛选。
- 批准号:
257256526 - 财政年份:2014
- 资助金额:
$ 52.19万 - 项目类别:
Research Fellowships
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8828181 - 财政年份:2013
- 资助金额:
$ 52.19万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8520690 - 财政年份:2013
- 资助金额:
$ 52.19万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8629741 - 财政年份:2013
- 资助金额:
$ 52.19万 - 项目类别:
Effect of exercise training on formation of brite adipocytes within white adipose tissue
运动训练对白色脂肪组织内脂肪细胞形成的影响
- 批准号:
23700778 - 财政年份:2011
- 资助金额:
$ 52.19万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Investigation for the mechanisms of the emergence of brown adipocytes in white adipose tissue
白色脂肪组织中棕色脂肪细胞出现机制的研究
- 批准号:
21780261 - 财政年份:2009
- 资助金额:
$ 52.19万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
LOUISIANA COBRE: P1: INDUCE THERMOGENIC BROWN ADIPOCYTES IN WHITE ADIPOSE TISSUE
路易斯安那 COBRE:P1:在白色脂肪组织中诱导产热棕色脂肪细胞
- 批准号:
7610781 - 财政年份:2007
- 资助金额:
$ 52.19万 - 项目类别: